Philip Morris submits applications to commercialize IQOS ILUMA to FDA

Philip Morris International submitted Premarket Tobacco Product Applications, PMTAs, and Modified Risk Tobacco Product Applications, MRTPAs, for IQOS ILUMA heated tobacco products with the FDA. A PMTA marketing order is required to commercialize any new tobacco product in the United States. The company is also seeking an order to market IQOS ILUMA products as modified risk products that reduce exposure to harmful, and potentially harmful chemicals, a claim authorized for previous versions of IQOS.